These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38587563)

  • 1. Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer.
    Fröhlich AK; Porthun J; Talha KM; Lena A; Hadzibegovic S; Wilkenshoff U; Sonntag F; Nikolski A; Ramer LV; Zeller T; Keller U; Bullinger L; Anker SD; Haverkamp W; von Haehling S; Doehner W; Rauch U; Skurk C; Cleland JGF; Butler J; Coats AJS; Landmesser U; Karakas M; Anker MS
    Clin Res Cardiol; 2024 Apr; ():. PubMed ID: 38587563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK; Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG; Ropelato MG; Domené HM; Pennisi P; Heinrich JJ; Jasper HG
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus.
    Clayton KL; Holly JM; Carlsson LM; Jones J; Cheetham TD; Taylor AM; Dunger DB
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):517-24. PubMed ID: 7955462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
    Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
    Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth.
    McIntyre HD; Serek R; Crane DI; Veveris-Lowe T; Parry A; Johnson S; Leung KC; Ho KK; Bougoussa M; Hennen G; Igout A; Chan FY; Cowley D; Cotterill A; Barnard R
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1143-50. PubMed ID: 10720053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels.
    Fusco A; Miele L; D'Uonnolo A; Forgione A; Riccardi L; Cefalo C; Barini A; Bianchi A; Giampietro A; Cimino V; Landolfi R; Grieco A; De Marinis L
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):531-6. PubMed ID: 22077984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
    Attie KM; Julius JR; Stoppani C; Rundle AC
    J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity growth hormone (GH)-binding protein (GHBP), body fat mass, and insulin-like growth factor-binding protein-3 predict the GHBP response to GH therapy in adult GH deficiency syndrome.
    Roelen CA; Koppeschaar HP; de Vries WR; Doerga ME; Snel YE; Bol E; Zelissen PM; Thijssen JH; Blankenstein MA
    Metabolism; 1999 Mar; 48(3):314-8. PubMed ID: 10094106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH-binding protein in obese men with varying glucose tolerance: relationship to body fat distribution, insulin secretion and the GH-IGF-I axis.
    Nam SY; Kim KR; Song YD; Lim SK; Lee HC; Huh KB
    Eur J Endocrinol; 1999 Feb; 140(2):159-63. PubMed ID: 10069661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment.
    Mandel S; Moreland E; Nichols V; Hanna C; Lafranchi S
    J Clin Endocrinol Metab; 1995 Jan; 80(1):190-4. PubMed ID: 7530256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3.
    Pirazzoli P; Cacciari E; De Iasio R; Pittalis MC; Dallacasa P; Zucchini S; Gualandi S; Salardi S; David C; Boschi S
    Arch Dis Child Fetal Neonatal Ed; 1997 Sep; 77(2):F100-4. PubMed ID: 9377129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone (GH) status regulates GH receptor and GH binding protein mRNA in a tissue- and transcript-specific manner but has no effect on insulin-like growth factor-I receptor mRNA in the rat.
    Butler AA; Funk B; Breier BH; LeRoith D; Roberts CT; Gluckman PD
    Mol Cell Endocrinol; 1996 Feb; 116(2):181-9. PubMed ID: 8647318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment.
    Low LC; Postel-Vinay MC; Kwan EY; Cheung PT
    Clin Endocrinol (Oxf); 1998 May; 48(5):641-6. PubMed ID: 9666877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.